Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Osteotech's DBM products:

This article was originally published in Clinica

Executive Summary

Osteotech has received from the US FDA three 510(k) marketing clearances for demineralised bone grafts in its DBM family of products. One clearance is for its Viagraf DBM paste, for use in filling bone defects in the extremities that might have been created surgically or by traumatic injury to the bone. The other two clearances cover the firm's Grafton Plus DBM paste for use in orthopaedic procedures and for use in dental, oral and cranio/maxillofacial procedures. The Eatontown, New Jersey firm has two more 510(k) applications for its DBM product pending clearance.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058153

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel